Format

Send to

Choose Destination
Toxicol Appl Pharmacol. 2019 Aug 8:114708. doi: 10.1016/j.taap.2019.114708. [Epub ahead of print]

Corrigendum to "Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway". [Toxicology and Applied Pharmacology 292 (2016) 19-29].

Author information

1
College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.
2
College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China. Electronic address: jinyongpeng2008@126.com.
PMID:
31401032
DOI:
10.1016/j.taap.2019.114708

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center